Evidence map›Paper›PMID 19087201›Full record

ArticleFEMS immunology and medical microbiology2009

Substitution of methionine 63 or 83 in S100A9 and cysteine 42 in S100A8 abrogate the antifungal activities of S100A8/A9: potential role for oxidative regulation.

Herve Y Sroussi, Gerwald A Köhler, Nina Agabian, Dana Villines, Joel M Palefsky

Open access · bronzeAbstract read
In one paragraph

Article in FEMS immunology and medical microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. The Role of Zinc in Gliotoxin Biosynthesis ofInternational journal of molecular sciences · 2019
    Article
  9. The relationship between DJ-1 and S100A8 in human primary alveolar type II cells in emphysema.American journal of physiology. Lung cellular and molecular physiology · 2019
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. S-glutathionylation regulates inflammatory activities of S100A9.The Journal of biological chemistry · 2010
    Article
  20. ANTI-INFECTIVE PROTECTIVE PROPERTIES OF S100 CALGRANULINS.Anti-inflammatory & anti-allergy agents in medicinal chemistry · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Herve Y SroussiDepartment of Oral Medicine and Diagnostic Sciences, UIC College of Dentistry (M/C 838), University of Illinois, Chicago, IL 60612-7213, USA. sroussih@uic.edu
Gerwald A Köhler
Nina Agabian
Dana Villines
Joel M Palefsky
University of California, San Francisco · USIllinois College · USOklahoma State University Center for Health Sciences · USUniversity of Illinois Urbana-Champaign · US

Funding

ORAL MANIFESTATIONS OF THE ACQUIRED IMMUNODEFICIENCY SP01DE007946 · NIDCR · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI GREENSPAN, JOHN S · 1987 to 2004
$5.8M
NANOMECHANICAL PROPERTIES OF CALCIFIED TISSUESK16DE000386 · NIDCR · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI MARSHALL, GRAYSON W · 1996 to 2003
$1.2M
CELL AND MOLECULAR BASIS OF ORAL BIOLOGYT32DE007204 · NIDCR · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI DAMSKY, CAROLINE H · 1989 to 2004
$818k
CALPROTECTIN AS A MOLECULAR SENSOR AND REGULATOR OF OXIDATION IN WOUND HEALINGK22DE017161 · NIDCR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SROUSSI, HERVE Y · 2006 to 2009
$637k
NIDCR NIH HHS K16 DE000386NIDCR NIH HHS K16 DE 00386NIDCR NIH HHS K22 DE017161NIDCR NIH HHS K22DE017161-02NIDCR NIH HHS P01 DE007946NIDCR NIH HHS P01 DE 07946NIDCR NIH HHS T32 DE007204NIDCR NIH HHS T32 DE07204
6 · The paper itself

Abstract

S100A8 and S100A9 and their heterocomplex calprotectin (S100A8/A9) are abundant cytosolic constituents in human neutrophils previously shown to possess antifungal activity. This study was designed to investigate mechanisms involved in the modulation of the antifungal properties of S100A8/A9. S100A8, S100A9 and site-directed mutants of both proteins were tested for their antifungal effect against Candida albicans in microplate dilution assays. Whereas S100A8 alone did not inhibit fungal growth, S100A9 by itself had a moderate antifungal effect. Combining both proteins had the strongest effect. Supporting a potential role for oxidation in S100A8/A9, substitution of methionine 63 or 83 of S100A9 resulted in the loss of antifungal activity. Additionally, the substitution to alanine of cysteine 42 of S100A8 also caused a loss of S100A8's ability to enhance S100A9's antifungal effect. Overall, our data indicate that both S100A8 and S100A9 are required for their fully active antifungal effect and that oxidation regulates S100A8/A9 antifungal activity through mechanisms that remain to be elucidated and evaluated. Finally, together with our previous work describing the oxidation-sensitive anti-inflammatory effects of S100A8/A9, we propose that S100A8/A9 exerts an anti-inflammatory activity in healthy state and that conditions associated with oxidative stress activate the antifungal activity of S100A8/A9.

Indexed as

Mutation, MissenseAntifungal AgentsCalgranulin ACalgranulin BCandida albicansHumansMicrobial Sensitivity TestsMutagenesis, Site-DirectedMutant ProteinsOxidation-ReductionAntifungal AgentsCalgranulin ACalgranulin BMutant Proteins

Identifiers

PMID19087201
PMCPMC2730662
OpenAlexW1968930078

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.